JULIANNE JOHNSON: Open Payments
NPI 1134832934 · FALMOUTH, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$184 in 8 payments from 5 companies in 2025. Trend: 2023 $278 · 2024 $328 · 2025 $184
Food & beverage: $184
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $82 |
| Novo Nordisk Inc | 2 | $48 |
| Merck Sharp & Dohme LLC | 1 | $21 |
| Lilly USA, LLC | 1 | $19 |
| Esperion Therapeutics, Inc. | 1 | $15 |
Products named: AIRSUPRA, Rybelsus, Ozempic, ZERBAXA, MOUNJARO, NEXLETOL.
Industry payments across MA — which companies pay providers there.
